• Je něco špatně v tomto záznamu ?

Association between circulating levels of C-reactive protein and positive and negative symptoms of psychosis in adolescents in a general population birth cohort

GM. Khandaker, J. Stochl, S. Zammit, G. Lewis, R. Dantzer, PB. Jones

. 2021 ; 143 (-) : 534-542. [pub] 20201117

Jazyk angličtina Země Velká Británie

Typ dokumentu časopisecké články, Research Support, N.I.H., Extramural, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc22003329

Grantová podpora
095844 Wellcome Trust - United Kingdom
RP-PG-0606-1335 Department of Health - United Kingdom
MC_PC_15018 Medical Research Council - United Kingdom
088869 Wellcome Trust - United Kingdom
201486 Wellcome Trust - United Kingdom
MR/L010305/1 Medical Research Council - United Kingdom
R01 NS073939 NINDS NIH HHS - United States
G9815508 Medical Research Council - United Kingdom
MC_PC_17213 Medical Research Council - United Kingdom
R01 CA193522 NCI NIH HHS - United States

BACKGROUND: Schizophrenia is associated with elevated levels of circulating C-reactive protein (CRP) and other inflammatory markers, but it is unclear whether these associations extend to psychotic symptoms occurring in adolescence in the general population. A symptom-based approach may provide important clues for apparent trans-diagnostic effect of inflammation, which is also associated with depression and other psychiatric disorders. METHODS: Based on data from 2421 participants from the Avon Longitudinal Study of Parents and Children birth cohort, we examined associations of serum CRP levels assessed around age 16 with ten positive and ten negative symptoms of psychosis assessed using questionnaires around age 17, using both individual symptoms and symptom dimension scores as outcomes. Regression models were adjusted for sex, body mass index, depressive symptoms, substance use, and other potential confounders. RESULTS: Most prevalent positive symptoms were paranoid ideation (4.8%), visual (4.3%) and auditory (3.5%) hallucinations. Negative symptoms were more strongly correlated with concurrent depressive symptoms (r=0.51; P < 0.001) than positive symptoms (rpb=0.19; P < 0.001). The associations of CRP with positive and negative symptom dimension scores were similar. At individual symptom level, after adjusting for potential confounders including depressive symptoms, CRP was associated with auditory hallucinations (adjusted OR = 2.22; 95% CI, 1.04-4.76) and anhedonia (adjusted OR = 1.13; 95% CI, 1.02-1.26). CONCLUSIONS: Inflammation is associated with sub-clinical psychotic symptoms in young people in general population. Association of CRP with symptoms commonly shared between mood and psychotic disorders, such as auditory hallucinations and anhedonia, could be one explanation for the apparent trans-diagnostic effect of inflammation.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22003329
003      
CZ-PrNML
005      
20220127150333.0
007      
ta
008      
220113s2021 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.jpsychires.2020.11.028 $2 doi
035    __
$a (PubMed)33229033
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Khandaker, Golam M $u Department of Psychiatry, University of Cambridge, Herchel Smith Building, Forvie Site, Cambridge Biomedical Campus, Cambridge, CB2 0SZ, United Kingdom; Cambridgeshire and Peterborough NHS Foundation Trust, Elizabeth House, Fulbourn Hospital, Fulbourn, Cambridge, CB21 5EF, United Kingdom. Electronic address: gmk24@medschl.cam.ac.uk
245    10
$a Association between circulating levels of C-reactive protein and positive and negative symptoms of psychosis in adolescents in a general population birth cohort / $c GM. Khandaker, J. Stochl, S. Zammit, G. Lewis, R. Dantzer, PB. Jones
520    9_
$a BACKGROUND: Schizophrenia is associated with elevated levels of circulating C-reactive protein (CRP) and other inflammatory markers, but it is unclear whether these associations extend to psychotic symptoms occurring in adolescence in the general population. A symptom-based approach may provide important clues for apparent trans-diagnostic effect of inflammation, which is also associated with depression and other psychiatric disorders. METHODS: Based on data from 2421 participants from the Avon Longitudinal Study of Parents and Children birth cohort, we examined associations of serum CRP levels assessed around age 16 with ten positive and ten negative symptoms of psychosis assessed using questionnaires around age 17, using both individual symptoms and symptom dimension scores as outcomes. Regression models were adjusted for sex, body mass index, depressive symptoms, substance use, and other potential confounders. RESULTS: Most prevalent positive symptoms were paranoid ideation (4.8%), visual (4.3%) and auditory (3.5%) hallucinations. Negative symptoms were more strongly correlated with concurrent depressive symptoms (r=0.51; P < 0.001) than positive symptoms (rpb=0.19; P < 0.001). The associations of CRP with positive and negative symptom dimension scores were similar. At individual symptom level, after adjusting for potential confounders including depressive symptoms, CRP was associated with auditory hallucinations (adjusted OR = 2.22; 95% CI, 1.04-4.76) and anhedonia (adjusted OR = 1.13; 95% CI, 1.02-1.26). CONCLUSIONS: Inflammation is associated with sub-clinical psychotic symptoms in young people in general population. Association of CRP with symptoms commonly shared between mood and psychotic disorders, such as auditory hallucinations and anhedonia, could be one explanation for the apparent trans-diagnostic effect of inflammation.
650    _2
$a mladiství $7 D000293
650    _2
$a C-reaktivní protein $x analýza $7 D002097
650    _2
$a lidé $7 D006801
650    _2
$a zánět $7 D007249
650    _2
$a longitudinální studie $7 D008137
650    12
$a psychotické poruchy $x epidemiologie $7 D011618
650    12
$a schizofrenie $x epidemiologie $7 D012559
655    _2
$a časopisecké články $7 D016428
655    _2
$a Research Support, N.I.H., Extramural $7 D052061
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Stochl, Jan $u Department of Psychiatry, University of Cambridge, Herchel Smith Building, Forvie Site, Cambridge Biomedical Campus, Cambridge, CB2 0SZ, United Kingdom; Department of Kinanthropology, Charles University, José Martího 31, Prague, 165 52, Czech Republic
700    1_
$a Zammit, Stanley $u Centre for Academic Mental Health, Department of Population Health Sciences, Bristol Medical School, University of Bristol, Oakfield House, Oakfield Grove, Bristol, BS8 2BN, United Kingdom; Institute of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, CF10 3AT, United Kingdom
700    1_
$a Lewis, Glyn $u Division of Psychiatry, University College London, Maple House, 149 Tottenham Court Road, London, W1T 7NF, United Kingdom
700    1_
$a Dantzer, Robert $u Department for Symptom Research, University of Texas MD Anderson Cancer Center, Laboratory of Neuroimmunology, Unit 1055, Office: Z8.5042, 6565 MD Anderson Boulevard, Houston, TX, 77030, USA
700    1_
$a Jones, Peter B $u Department of Psychiatry, University of Cambridge, Herchel Smith Building, Forvie Site, Cambridge Biomedical Campus, Cambridge, CB2 0SZ, United Kingdom; Cambridgeshire and Peterborough NHS Foundation Trust, Elizabeth House, Fulbourn Hospital, Fulbourn, Cambridge, CB21 5EF, United Kingdom
773    0_
$w MED00002912 $t Journal of psychiatric research $x 1879-1379 $g Roč. 143, č. - (2021), s. 534-542
856    41
$u https://pubmed.ncbi.nlm.nih.gov/33229033 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220113 $b ABA008
991    __
$a 20220127150329 $b ABA008
999    __
$a ok $b bmc $g 1750945 $s 1154478
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 143 $c - $d 534-542 $e 20201117 $i 1879-1379 $m Journal of Psychiatric Research $n J Psychiatr Res $x MED00002912
GRA    __
$a 095844 $p Wellcome Trust $2 United Kingdom
GRA    __
$a RP-PG-0606-1335 $p Department of Health $2 United Kingdom
GRA    __
$a MC_PC_15018 $p Medical Research Council $2 United Kingdom
GRA    __
$a 088869 $p Wellcome Trust $2 United Kingdom
GRA    __
$a 201486 $p Wellcome Trust $2 United Kingdom
GRA    __
$a MR/L010305/1 $p Medical Research Council $2 United Kingdom
GRA    __
$a R01 NS073939 $p NINDS NIH HHS $2 United States
GRA    __
$a G9815508 $p Medical Research Council $2 United Kingdom
GRA    __
$a MC_PC_17213 $p Medical Research Council $2 United Kingdom
GRA    __
$a R01 CA193522 $p NCI NIH HHS $2 United States
LZP    __
$a Pubmed-20220113

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...